Cartesian Therapeutics, Inc. RNAC 35.83
Health Care · NASDAQ · Data as of 2026-04-30
Cartesian Therapeutics, Inc. (RNAC) has delivered +38.7% annualized revenue growth, n/a earnings growth, and n/a dividend growth over 10 years of data. Ranked #1670 of 1993 stocks overall and #211 of 264 in the Health Care sector by Steady Score.
Industry
Pharmaceutical Preparations
Steady Score
35.83
Overall Rank
#1670 / 1993
Sector Rank
#211 / 264
Revenue CAGR
+38.7%
Earnings CAGR
-
Dividend CAGR
-
?
E/R CAGR Ratio
-
Revenue
Earnings
Dividends
Free Cash Flow
Margin
NET Margin
FCF Margin
Payout Ratio
Payout Ratio
FCF Payout Ratio